A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for Alzheimer Disease
52 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 55+
Code: NCT07602582·Phase 3·Recruiting·Listed May 2026
Monroe Biomedical research
Clinical research site in Monroe, North Carolina · Monroe Biomedical Research, 343 Venus St, Monroe, NC 28112 · (704) 283-7369 · Website
Part of Monroe Biomedical Research
As of July 2026, 25 paid clinical trials are recruiting at Monroe Biomedical research in Monroe, North Carolina. Active studies at this site cover conditions such as Obesity, Overweight and Atherosclerotic Cardiovascular Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Monroe Biomedical research (25)
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
for Overweight
55 locations incl. Chandler
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07575932·Phase 2·Recruiting·Listed May 2026
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
for Overweight
40 locations incl. Chandler
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07589608·Phase 2·Recruiting·Listed May 2026
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
for Hypercholesterolaemia
26 locations incl. Foley
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 75
Code: NCT07610278·Phase 2·Recruiting·Listed May 27, 2026
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for Obesity
41 locations incl. Tuscaloosa
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07321886·Phase 3·Recruiting·Listed Jan 2026
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for Diabetic Peripheral Neuropathic Pain
75 locations incl. Birmingham
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 18 - 80
Code: NCT07231419·Phase 3·Recruiting·Listed Nov 2025
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
for Metabolic Dysfunction-Associated Steatotic Liver Disease
141 locations incl. Tuscaloosa
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07165028·Phase 3·Recruiting·Listed Sep 2025
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
94 locations incl. Peoria
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184931·Phase 3·Recruiting·Listed Sep 2025
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for Cardiovascular Disease
201 locations incl. Alexander City
Sponsor: Amgen
Sex: All·Age: 50 - 105
Code: NCT07136012·Phase 3·Recruiting·Listed Aug 2025
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
for Atherosclerotic Cardiovascular Disease
138 locations incl. Daphne
Sponsor: Amgen
Sex: All·Age: 45 - 99
Code: NCT07037433·Phase 3·Recruiting·Listed Jun 2025
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
91 locations incl. Peoria
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184996·Phase 3·Recruiting·Listed Sep 2025
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
for Obesity
43 locations incl. Chandler
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT06143956·Phase 2·Recruiting·Listed Nov 2023
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
for Coronavirus Disease (COVID-19)
61 locations incl. Paradise Valley
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06667700·Phase 3·Recruiting·Listed Oct 2024
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
for COVID-19 SARS-CoV-2 Infection
81 locations incl. Little Rock
Sponsor: Pfizer
Sex: All·Age: 12+
Code: NCT06679140·Phase 3·Recruiting·Listed Nov 2024
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
for High Risk Cardiovascular Disease
261 locations incl. Birmingham
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07181109·Phase 3·Recruiting·Listed Sep 2025
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
for Major Depressive Disorder
43 locations incl. Phoenix
Sponsor: Cybin IRL Limited
Sex: All·Age: 18 - 85
Code: NCT06564818·Phase 3·Recruiting·Listed Aug 2024
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for Moderately to Severely Active Crohns Disease
92 locations incl. Dothan
Sponsor: Hoffmann-La Roche
Sex: All·Age: 16 - 80
Code: NCT06819878·Phase 3·Recruiting·Listed Feb 2025
Pelacarsen Roll-over Extension Program
for Atherosclerotic Cardiovascular Disease
78 locations incl. Birmingham
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT06875973·Phase 3·Recruiting·Listed Mar 2025
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
for Difficult to Control Hypertension
26 locations incl. Little Rock
Sponsor: E-Star BioTech, LLC
Sex: All·Age: 18 - 80
Code: NCT06343298·Phase 2·Recruiting·Listed Apr 2024
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
for Obesity
13 locations incl. Northridge
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07225686·Phase 3·Recruiting·Listed Nov 2025
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
for Obstructive Sleep Apnea
13 locations incl. Northridge
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07226765·Phase 3·Recruiting·Listed Nov 2025
A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
for Obesity & Overweight
3 locations incl. Louisville
Sponsor: ERX Pharmaceuticals
Sex: All·Age: 18 - 60
Code: NCT07570758·Phase 2·Recruiting·Listed May 2026
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
for Hypertension (HTN)
9 locations incl. Garden Grove
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07543120·Phase 2·Recruiting·Listed Apr 2026
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
for Ulcerative Colitis
8 locations incl. Lancaster
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT06979336·Phase 2·Recruiting·Listed May 2025
Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.
for Diabetic Foot Ulcer
1 location in Monroe
Sponsor: Samaritan Biologics
Sex: All·Age: 18+
Code: NCT06437028·Recruiting·Listed May 2024
More research sites in Monroe
- Atrium Health Union/LCI-Union (17 trials)
- Atrium Health Union (biopsy only) (1 trial)
- Clinical Trial Site (1 trial)
- Levine Cancer Institute (1 trial)
- Monroe Biomedical Research -343 Venus St (1 trial)
- Monroe Biomedical Research, LLC (1 trial)
- Retension Clinical Site (1 trial)
Explore more
Paid clinical trials in Monroe, NC · North Carolina clinical trials